Metraipolis › archive › dc_6beaaaa3578e
Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta-Analysis — Europe PMC PMID:42120997
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42120997
- DOI
- 10.1002/edm2.70238
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T22:43:18.752Z
- SHA-256 of the archived text
aea5c16c6c1856922a387410eddc3f65718a2507e940b15fbadcb2328358d5f1- Stable URL of this page
https://metraipolis.com/documento/dc_6beaaaa3578e
How to cite
Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta-Analysis — Europe PMC PMID:42120997 — Europe PMC (en), https://europepmc.org/article/MED/42120997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6beaaaa3578e (Metraipolis archive dc_6beaaaa3578e, sha256 aea5c16c6c1856922a387410eddc3f65718a2507e940b15fbadcb2328358d5f1)
BibTeX
@misc{dc6beaaaa3578e,
title = {Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta-Analysis — Europe PMC PMID:42120997},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42120997},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6beaaaa3578e; sha256 aea5c16c6c1856922a387410eddc3f65718a2507e940b15fbadcb2328358d5f1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42120997. Agents can read the archived copy with the MCP tool read_document.